Nine independent mutants deficient in tryptophanase activity were isolated. Each mutation was transferred to a specialized transducing phage that carries the tryptophanase region of the Escherichia coli chromosome. The nine phages thus produced, and a tenth carrying a previously characterized tryptophanase mutation, were used to lysogenize a bacterial strain harbouring a mutation in the tryptophanase structural gene and also a suppressor of polarity. In no case was complementation observed; we conclude that there is no closely linked positive regulatory gene for tryptophanase.
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RESULTS

Isolation of new tryptophanase-deJicient mutants
We used the technique of directed mutagenesis (Hong & Ames, 1971) to isolate mutants deficient in tryptophanase. This technique involves growing generalized transducing phage on a donor containing a marker for which there is a positive selection and which is closely linked to the gene in which mutations are desired, and transducing this marker into a suitable recipient after the phage preparation has been mutagenized in vitro. Some of the transductants thereby acquire mutations in the desired gene. We chose bglR, which is about 70% cotransducible with tna and tnaR, as the marker for which selection could be made. We therefore grew phage PI on MY711 (tnaf bgZR), mutagenized the preparation with hydroxylamine (Tully & Yudkin, 1977) , and used it to transduce MY1386 (trpdel AC9 ValR tnaf) to growth on salicin/minimal agar supplemented with tryptophan. (bglR strains can grow on salicin as sole source of carbon; bglRf strains cannot.) We replicated the transductants to salicin/minimal agar supplemented with indole and 5-methyltryptophan.
(tnaf trpdel strains can use indole as a source of tryptophan when expression of the tna gene is induced with 5-methyltryptophan ; tna trpdel strains cannot.) We isolated and tested all colonies that grew on salicin/tryptophan medium but not on salicin/indole/ 5-methyltryptophan medium and in this way obtained nine tryptophanase-deficient mutants out of about 15000 transductants. The mutations in these nine strains are called tnal0l to tnal09.
Transfer of the mutations to a specialized transducing phage We wanted to test all the new mutations for ability to complement a mutation (tnats6) that is known to lie in tna, the structural gene for the enzyme. In order to do so, we transferred each of them to the specialized transducing phage himm21tna+ (Borck et al., 1976) , so that we could then lysogenize the tnats6 strain with the set of tna phages. The method of recombining each mutation into himrn21 ?nuf was as follows.
We first grew phage PI on each of the nine new mutants and used the phage preparations to transduce MY678 [trpR trpde1BE9(atth-gal-bio)de1] to valineresistance. Since valine resistance is about 20 yo cotransducible with tna (Yudkin, 1976) , we were able to recover tryptophanasedeficient derivatives of MY678 from each transduction. We lysogenized these with hirnm21tnaf which, since the host is deleted for atth, can be integrated only near the chromosomal tna locus. We then induced the nine lysogens by ultraviolet irradiation. We expected that each of the resulting lysates would include two types of transducing particles -himm21 tnaf, and himm21 tna containing, as a result of recombination, the tryptophanase mutation present in the lysogen. [Since the transducing phage carries tnaR (R. M. Edwards, unpublished work), it would be able equally well to acquire a mutation in this locus if it were this that had originally led to the tryptophanase-deficient phenotype of the new mutants.]
We then used each of these unpurified lysates to lysogenize the homologous mutant strain in which the mutation was first identified. Each lysogeny mixture would be expected to contain both heterogenotes, e.g. tnalOl(himm21 ?nu+), and homogenotes, e.g. tnal0I (himm2ltnalOl), apart from bacteria that had not been lysogenized. The second of these classes can be recognized by the fact that although they are lysogens, i.e. immune to himm21c1, they are Tna-, i.e. unable to use indole as a source of tryptophan in the presence of 5-methyltryptophan. We purified lysogenic homogenotes from each of the nine mixtures and induced them. Phage was purified from each lysate by two serial platings on the homologous mutant strain, and by growth on the same strains we obtained high-titre stocks of nine phages of genotypes himm21 tnal01 to himm21 tnal09.
We proved that each of these phages carried the bacterial tna region, since each was able to recombine with several tna mutants to yield Tnaf transductants. However, when each Short communication 473 Table 1 . Tryptophanase activity of cultures grown at 40 "C Each strain was grown from a single colony in glycerol/minimal medium supplemented with Ltryptophan (100pgml-l)at 40 "C. When the cultures reached an A600 of 0.1 to 0.3,duplicate samples were taken into chloramphenicol (final concn 100 pg ml-l) and the bacteria were harvested by centrifugation. The cell pellets were washed twice and assayed for tryptophanase by the method of Yudkin (1976) . This procedure involves the conversion of tryptophan to indole, and the assay of the indole by formation of a 4-dimethylaminobenzaldehyde complex which absorbs at 568 nm. The results are expressed as the absorbance of this complex at 568 nm divided by the absorbance of the bacterial culture at 600 nm. This fraction is proportional to the tryptophanase activity per mg cell mass. Strain W 3 1 10 tna+ rhoZO3 W3110 tnats6 rhoZ03 W31 I0 tnats6 rho103(himm2ltna+ was used to lysogenize a strain carrying its own homologous mutation, the resulting lysogens (presumed to be homogenotes) all proved to be Tna-.
We also used a tenth himm21tna phage, himm21tna2. This contains the mutation tna2 and has been described previously (see Taylor & Yudkin, 1978) . Before the present experiments it had not been proved conclusively whether tna2 was located in the structural gene for tryptophanase.
Construction of diploid strains for complementation tests
The mutation tnats6 renders tryptophanase activity temperature-sensitive in cell-free extracts and has been proved to lie in the structural gene for the enzyme (Taylor & Yudkin, 1978) . We chose this as the reference mutation against which to test the ten other mutations for complementation, and transferred it to strain W3 1 10 by cotransduction with bgZR.
We now anticipated a possible difficulty in interpretation that might arise if the result of a complementation test appeared negative. The straightforward interpretation of such a result would be that the two mutations that failed to complement were in the same cistron. However, another possibility is that the two mutations are in different cistrons but in the same transcription unit, and that the failure to complement is due to polarity of the more promoter-proximal mutation. To avoid this difficulty, we introduced into W3 1 10 tnats6 the polarity-suppressing mutation rho103 (Korn & Yanofsky, 1976) by cotransduction with valine resistance (to which rho is very closely linked.) That the resulting strain W3 110 tnats6 rho103 did in fact contain the rho mutation was proved by the fact that phage P1 grown on it could suppress the polarity of two separate nonsense mutations (trpE9914 and ZacZUl18) in the same strain.
We lysogenized W3110 tnats6 rho103 with each of the ten himm21tna phages that we have described. We also lysogenized the strain with himm21tna+ (to serve as a positive control), and we made W3110 tnats6 rho103(h) by displacing himm21tna+ from the last-named strain with wild-type A.
.
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Results of the complementation tests Haploid strains containing tnats6 synthesize negligible quantities of active tryptophanase when grown in minimal medium with tryptophan at 40 "C (Taylor & Yudkin, 1978) . We therefore grew our strains at 40 "C and measured the activity of tryptophanase, expecting that complementation would lead to the appearance of active enzyme. From the results given in Table 1 , several conclusions are apparent.
(1) Strain W3110 tnats6 rho103 contains less than 2 % of the tryptophanase activity of the isogenic tna+ strain.
(2) Lysogeny of this strain with himm2ltna+ increases the tryptophanase activity more than 10-fold. We conclude that, as expected, himm21 tna+ complements tnats6. [We have repeatedly observed that various tna(himm2 1 tna+) strains make less tryptophanase than tna+ strains. We believe that tna on the prophage is transcribed from a bacterial promoter, as its expression is induced by tryptophan or 5-methyltryptophan, and subject to catabolite repression, like that of tna in the normal location; since the latter is very close to the origin of replication of the chromosome, there will be more copies per cell of the chromosomal tna than of htna, and this fact may in part account for the different rates of expression.]
(3) When himm21tna+ is removed by displacement with h the resulting lysogen makes almost no heat-stable tryptophanase.
(4) None of the ten himm21tna lysogens makes heat-stable tryptophanase; hence none of the ten mutations complements tnats6.
D I S C U S S I O N
Since the complementation tests were done in the presence of the polarity suppressor rhol03, the failure of the ten mutations tested to complement tnats6 cannot, in all probability, be explained by polarity. Although alternative explanations (such as a cis-acting regulatory gene) have not been rigorously excluded, we think it is reasonable to conclude that the ten mutations are, like tnats6, in the tryptophanase structural gene, and hence that none of them are in tnaR. However, tnaR is extremely close to tna (more than 98 yo cotransducible with phage P1) and one would have therefore expected it to be a target for mutagenesis by the method used.
The significance of the results can be discussed in the following way. Suppose that tnaR is a positive regulatory gene and that it can be mutated to give tryptophanase deficiency; what is the probability that out of ten tryptophanase-deficient mutants none should be in tnaR?
To assess this probability we make two assumptions. First, we assume that the mutability of tnaR per unit length is the same as that of tna. (We note that mutations leading to loss of activity of the positive regulator can readily be obtained in such systems as araC, cysB, dsdC and malT.) Secondly, we assume that the molecular weight of the (monomeric) protein hypothetically encoded by tnaR is 28000. [This figure is chosen as equal to the smallest of three known bacterial regulatory proteins: araC (28000; Wilcox et al., 1974) , lacZ(38 000; Gilbert & Muller-Hill, 1970) and cysB (39 000; D. M. Mascarenhas, unpublished work).] The molecular weight of the monomer encoded by tna is 56000 (London & Goldberg, 1972) . Then, the probability that ten out of ten mutations leading to tryptophanase deficiency should all lie in tna is = 0.017 ( 56000 )lo = (?)lo 56 000 + 28 000
Hence, if the assumptions we have made are correct, the probability that tnaR encodes a On: Mon, 31 Dec 2018 16:43:16 Short communication 475 positive regulatory protein but that we have failed to find negative mutations in tnaR is less than 2%. We conclude that it is unlikely that tnaR is a positive regulatory gene, unless it is very small or immutable.
We are indebted to Mr R. M. Edwards for valuable suggestions and for allowing us to cite some of his experimental results. 
